629 4,6-Dichloropyrimidine for Sale
2-Methoxy-4,6-dichloropyrimidine
-
CAS No.:
1074-40-4
-
Content:
98%
-
Packaging:
as customers' requirements
2-Amino-4,6-dichloropyrimidine
-
CAS No.:
56-05-3
-
Content:
98%
-
Packaging:
as customers' requirements
5-Amino-4,6-dichloropyrimidine
-
CAS No.:
5413-85-4
CAS 56-05-3 2-Amino-4,6-dichloropyrimidine
-
CAS No.:
56-05-3
-
Content:
98%
-
Packaging:
25kg/fiber can
4,6-dichloropyrimidine-5-carboxaldehyde
-
CAS No.:
5305-40-8
-
Content:
99%
-
Packaging:
drum
5-Amino-4,6-dichloropyrimidine
-
CAS No.:
5413-85-4
About 4,6-Dichloropyrimidine List
- Buying Tirzepatide on www.echemi.com where you will find large variety of good choices. The suppliers of 629 Tirzepatide on the search result are been verified by the accurate information of each one. Safe transaction of chemical will be made based on true information. We help you get chemicals in need continuously and meet registered Tirzepatide suppliers.
- We guarantee the quality of Tirzepatide 2023788-19-2 on ECHEMI. Our business partners are with certification, quanlification and so on. We help buyers to get Tirzepatide with various requirement and regulations in global countries and regions. Customized services of Tirzepatide will provided to customers on ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Registered member can enjoy more services of Tirzepatide on with market price and insights, global news, trade data and so on. You can enjoy the chemical supply chain services on ECHEMI. ECHEMI is helping you of Tirzepatide with global procurement service.
Check Out More Resources
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide
-
QIngdao Sigma Chemical Co.,Ltd
-
Dongguan Chenguang Technology Co., Ltd.
-
BrightGene Health Technology Co., Ltd
-
Synpeptide Co., Ltd
-
Maintain Biotech Co.Ltd
-
NANJING HANXIN PHARMACEUTICAL TECHNOLOGY
-
Hangzhou Go Top Peptide Biotech Co.,Ltd.
-
Deepharma Peptides/supplement
-
Xiamen Top Health Biochem Tech. Co.,Ltd
-
Hestar Biotech